 |
Chris Baran, Ph.D.
Research Scientist
201 Davis Heart & Lung Research Institute
473 West 12th Avenue
Columbus, OH 43210
(614) 366-1332
Education :
B.A., Chemistry and Business ,Washington and Jefferson College, 1997
PhD, Biochemistry, The Ohio State University, 2003
Mentor: Clay Marsh, MD
Research Interests:
Alveolar macrophage function in lung disease
The role of M-CSF in the pathogenesis of idiopathic pulmonary fibrosis
The molecular details surrounding the influence of inflammation on interstitial lung diseases
The importance of fibrocytes in fibrotic lung injury and inflammation
Awards and Honors:
2002 Outstanding presenter at Bennett Graduate Research Society Meeting for The Ohio State University College of Medicine and Public Health
2004 Appointed position as a Post-doctoral Fellow for the Department of Internal Medicine
2006 Member of the American Thoracic Society
2006 Selected for Oral Presentation for the 2006 American Thoracic Society Meeting: Clinical Minisymposium on Idiopathic Pulmonary Fibrosis
2006 1st Place: Outstanding faculty research presentation. 1st Annual Pulmonary Research Conference. Columbus, OH
2007 1st Place: Outstanding Research Scientist Presentation. The Dorothy M. Davis Heart and Lung Research Institute Research Symposium, The Ohio State University College of Medicine. Columbus, OH
Grant Awards:
T32 HL07946-01, Wewers (PI) 2004 – 2006 NIH / NHLBI, Role: Post-doctoral Fellow
Publications:
-
Bringardner BD, Baran CP, Eubank TD, and Marsh CB. Forum Review: The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxidants and Redox Signaling. (2007) IN PRESS.
-
Baran CP, Opalek JM, McMaken S, Newland CA, Hunter MG, O'Brien JM, Bringardner BD, Monick MM, Brigstock DR, Stromberg PC, Hunninghake GW, and Marsh CB. Important roles for M-CSF, CCL2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. (2007) American Journal of Respiratory and Critical Care Medicine, 2007 Jul 1;176(1):78-89.
-
Bhatt N, Baran CP, Allen J, Magro C, and Marsh CB. Promosing pharmacologic innovations in treating pulmonary fibrosis. (2006) Current Opinion in Pharmacology 6 (3), 284-92.
-
Varadharaj S, Steinhour E, Hunter MG, Watkins T, Baran CP, Magalang U, Kuppusamy P, Zweir JL, Marsh CB, Natarajan V, and Parinandi NL. Vitamin C-induced activation of phospholipase D in lung microvascular endothelial cells: Regulation by MAP kinases. (2006) Cell Signaling 18 (9), 1396-1407.
-
Baran CP, Zeigler MM, Tridandapani S, and Marsh CB. The role of ROS and RNS in regulating life and death of blood monocytes. (2004) Current Pharmeceutical Design 8, 855-66.
-
Baran CP, Tridandapani S, Helgason CD, Humphries RK, Krystal G, and Marsh CB. The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity. (2003) The Journal Biological Chemistry 278, 38628-36.
-
Tridandapani S, Wardrop R, Baran CP, Wang Y, Opalek JM, Caligiuri MA, and Marsh CB. TGF-beta 1 suppresses myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit. (2003) The Journal of Immunology 170, 4572-7.
-
Chiu IM, Touhalisky K, and Baran CP. Multiple controlling mechanisms of FGF1 gene expression through multiple tissue-specific promoters. (2001) Progress in Nucleic Acids research and Molecular Biology 70, 155-74.
|
